Octreotide Synthesis via Solid-Phase Peptide Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional synthesis methods for octreotide and its derivatives are complex, costly, and inefficient, with low yields and poor purity due to the difficulty in forming disulfide bonds and the use of hazardous reagents, leading to challenges in achieving high molecular weight peptide synthesis.
Innovation Solution
A novel solid-phase peptide synthesis process using H-Cys (Trt)-2-chlorotrityl resin, coupling with polar aprotic solvents, and hydrogen peroxide for oxidation at acidic pH to form octreotide, avoiding hazardous thiol scavengers and achieving high purity and yield through chromatographic purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional solution phase synthesis is used, then octreotide can be synthesized, but the process is time-consuming with multi-step synthesis and difficult separation leading to low productivity
Solution Approach 1:
The patent replaces conventional solution phase chemical synthesis with solid phase peptide synthesis (SPPS), where the peptide is synthesized while attached to a solid support resin. This substitution enables automated synthesis, simplifies purification through filtration, and dramatically reduces synthesis time while maintaining high yield and purity of octreotide.
2Manufacturing precision
If conventional solid phase synthesis with Threoninol residue protection is used, then octapeptide formation is achieved, but the process requires mandatory protection of Threoninol residue and complex deprotection steps increasing device complexity
Solution Approach 1:
The patent extracts the Threoninol residue protection problem from the synthesis pathway by using a different C-terminal residue (Alaninol or Homoinol) that does not require protection. This extraction eliminates the need for complex acetal protection and deprotection steps, simplifying the overall synthesis process while maintaining octapeptide formation accuracy.
Solution Approach 2:
Instead of protecting the Threoninol residue as conventionally done, the patent inverts the approach by selecting alternative C-terminal residues (Alaninol/Homoinol) that are inherently stable and do not require protection. This inversion of the protective strategy eliminates unnecessary steps and reduces device complexity.
3Reliability
If hazardous reagents and thiol scavengers are used in conventional synthesis, then disulfide bond formation is achieved, but environmental harm and safety issues arise worsening object-affected harmful factors
Solution Approach 1:
The patent changes the chemical parameters of the oxidation process by using hydrogen peroxide (H2O2) as the oxidizing agent instead of conventional hazardous reagents like iodine or peracids. Hydrogen peroxide decomposes into water and oxygen, eliminating the need for thiol scavengers and reducing environmental harm while maintaining reliable disulfide bond formation in octreotide.
Solution Approach 2:
The patent employs hydrogen peroxide, a cheap and environmentally benign oxidizing agent that decomposes completely into water and oxygen. This disposable reagent eliminates the need for complex waste treatment systems and thiol scavengers, reducing both cost and environmental impact while achieving reliable cyclization.
4Manufacturing precision
If complex purification processes are used in conventional synthesis, then octreotide purity can be improved, but the process becomes costly and time-consuming worsening productivity
Solution Approach 1:
The patent performs preliminary action by incorporating purity-enhancing features during the synthesis stage itself. The solid phase synthesis methodology inherently produces high purity peptides through automated coupling and washing steps, and the use of stable C-terminal residues prevents side reactions. This preliminary purification during synthesis reduces the need for complex post-synthesis purification steps.
Solution Approach 2:
The patent maintains continuity of useful action throughout the synthesis process by using solid phase methodology where each coupling step is followed by thorough washing that removes excess reagents and byproducts. This continuous purification during synthesis maintains high product purity without requiring separate intensive purification steps, thereby improving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves a purity of >99% and yield of 95% with simplified steps, avoiding racemization and side reactions, and is environmentally friendly and cost-effective.
Implementation Method 1
oxidizing the deprotected peptide in the presence of hydrogen peroxide to yield a clean crude cyclic octapeptide
Data Source
AI summary
This invention relates a process for preparing octreotide and derivatives thereof. The starting material, Cys(Trt)-2-Chlorotrityl resin is coupled with various amino acids to obtain a protected heptapeptide of formula (2): Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(OBut)-Cys(Trt)-2-Chlorotrityl resin. The linear protected peptide of formula (2) is cleaved from the support using TFA5TIS and water to yield linear protected peptide of formula (3) Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(OBut)-Cys(Trt)-OH Linear protected heptapeptide of formula (3) is deprotected to yield heptapeptide of formula (6): D-Phe-Cys-Phe-D-Tip-Lys-Thr-Cys-OH; which is cyclized using hydrogen peroxide and to the cyclic peptide of formula (7) D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-OH; threoninol is coupled at C terminal to yield octreotide. Alternatively threoninol is coupled to the heptapeptide of formula (3) to yield protected octapeptide of formula (4) Boc-D-Phe-Cys(Trt)-Phe-D-Trp-Lys(Boc)-Thr(OBut)-Cys(Trt)-Thr-OL which is subsequently deprotected to yield linear octapeptide of formula (5) D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-OL and cyclized with hydrogen peroxide to yield cyclic octreotide with a yield of >95%.